Navigation Links
ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development
Date:10/15/2008

Solidifies Company's Leadership Position in Targeting Chemokine Receptor

CCR9 for Gastrointestinal Diseases

MOUNTAIN VIEW, Calif., Oct. 15 /PRNewswire/ -- ChemoCentryx, Inc., announced today that it has initiated a Phase I clinical trial of CCX025, the company's fourth investigational new drug and second orally administered compound that inhibits the chemokine receptor known as CCR9. Structurally distinct from Traficet-EN(TM) (CCX282-B; ChemoCentryx's CCR9 antagonist currently in a Phase II/III clinical trial for Crohn's disease), CCX025 strengthens ChemoCentryx's position in the CCR9 arena and expands the company's gastrointestinal franchise with the potential to pursue different clinical indications with discrete compounds.

"With the advancement of CCX025 into the clinic, ChemoCentryx can pursue a greater breadth of diseases associated with CCR9 receptor inhibition with the clear advantage of having two structurally distinct, very potent and highly-selective oral therapeutics," said Thomas J. Schall, Ph.D., President and Chief Executive Officer of ChemoCentryx. "CCX025 is our fourth product candidate in the clinic, all discovered and developed at ChemoCentryx, and establishes our position as a leader in the industry in developing chemokine-based therapeutics."

The Phase I double-blind, placebo-controlled trial of CCX025 is being conducted in healthy male and female volunteers to evaluate the safety, tolerability and pharmacokinetics of CCX025 over a range of dose levels. In preclinical studies, the compound has been shown to be well-tolerated and highly selective. Like Traficet-EN, CCX025 is differentiated from existing inflammatory bowel disease therapies such as biologics (which are typically injected or infused), steroids and immunosuppressives and may offer a novel, safe and conveniently administered treatment option.

CCX025 and Traficet-EN are oral, highly-specific inhibitors of the chemokine receptor kn
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth
2. Will New Technological Advances Offer Fresh Capabilities for Commercialization and Enhance BTL Investments?
3. Ardea Biosciences Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout
4. New molecular imaging techniques may lead to advances in disease treatment
5. Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs
6. Regenesis Biomedical Advances Corporate Strategy by Appointing Vice President of Marketing
7. Sirion Therapeutics Preclinical Studies: Two New Potential Advances in Treatment of Retinal Diseases to be Presented at ARVO
8. Human Genome Sciences Advances Oncology Portfolio
9. ITSSD: Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innovation Model
10. Genetic Engineering & Biotechnology News reports on advances in miRNA
11. Malaysia Genome Institute Advances Bioinformatics Research Using SGI Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... have developed a technique for controlling the surface tension ... the door to a new generation of reconfigurable electronic ... the fact that the oxide "skin" of the metal ... as a surfactant, lowering the surface tension between the ... a liquid metal alloy of gallium and indium. In ...
(Date:9/15/2014)... idea of fibers made of carbon nanotubes is neat, but ... The single-walled carbon nanotubes in new fibers created at Rice ... process designed by chemist Angel Mart and his colleagues. , ... results this month in the journal ACS Nano , ... together into a fiber. , Left to their own devices, ...
(Date:9/15/2014)... Bioptigen announced today the availability ... the optical device metrology and pre-clinical ophthalmic research markets. ... for Contact Lens Metrology is designed for non-destructive, non-contact, ... lens, IOL structures, and donor tissues. The ... immersed in a hydration bath (saline), automated segmentation of ...
(Date:9/15/2014)...  iVinci Health LLC, the company behind the healthcare ... branded as VisitPay®, has successfully closed $5 million in ... a new extension to VisitPay® – an online Payment ... way for patients to manage their medical bills and ... their families. The new round of funding, ...
Breaking Biology Technology:Researchers control surface tension to manipulate liquid metals 2Rice rolls 'neat' nanotube fibers 2Rice rolls 'neat' nanotube fibers 3Bioptigen Introduces Deep Imaging OCT System for Contact Lens Metrology 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 3
... quandary this week: I have a number of juicy topics ... in the annual Israel biotech/medical device conference (BIOMED 2006), recent ... the Indian biotech market, happenings in Japan, and other research ... also started thinking back on why I originally wanted to ...
... - Calling the destruction of human embryos a ... vetoed a bill that would have overturned his ban on new ... attempt failed in the House of Representatives. , ,"It crosses a ... vetoed it," Bush said in announcing the veto, the first of ...
... rate of development in the information technology industry occasionally ... the field. Staying astride the flow of technological advances ... students alike. , ,That is why IT experts must ... assistance, especially when the goal is educating the next ...
Cached Biology Technology:The world of in-vitro diagnostics is another Midwest success story 2The world of in-vitro diagnostics is another Midwest success story 3The world of in-vitro diagnostics is another Midwest success story 4The world of in-vitro diagnostics is another Midwest success story 5The world of in-vitro diagnostics is another Midwest success story 6Bush vetoes stem cell research bill 2Bush vetoes stem cell research bill 3MATC boot camp keeps IT instructors up to date 2MATC boot camp keeps IT instructors up to date 3MATC boot camp keeps IT instructors up to date 4MATC boot camp keeps IT instructors up to date 5
(Date:9/16/2014)... years after the Hesperides vessel returned to Spain culminating ... have an increasingly clear picture of how the global ... the input of pollutants from the atmosphere is not ... most remote areas of the planet, and it is ... are presented this week in CSIC Residence for Researchers ...
(Date:9/16/2014)... have all seen a peacock show its extravagant, colorful ... group of researchers have used a special camera developed ... to discover that female northern swordtail fish choose their ... at the University of Texas at Austin used a ... professor of computer science & engineering at Washington University, ...
(Date:9/16/2014)... From the salmon-rich waters of Southeast Alaska to ... Downeast Maine,s lobster, lumber and tourist towns, coastal residents ... about coastal environments divide along political lines. That,s a ... New Hampshire sociologists published this month in the journal ... a lot of environment-related differences from place to place ...
Breaking Biology News(10 mins):The Malaspina Expedition confirms that pollution reaches even the most remote areas of the ocean 2The Malaspina Expedition confirms that pollution reaches even the most remote areas of the ocean 3Camera developed at WUSTL sheds light on mate choice of swordtail fish 2Politics divide coastal residents' views of environment, UNH research finds 2Politics divide coastal residents' views of environment, UNH research finds 3
... National Institutes of Health today announced it has awarded ... demonstration projects designed to link changes in the human ... support investigators to develop innovative technologies to improve the ... microbiome. The human microbiome comprises all the ...
... have been added to the slate of expertswhich ... Symposium: Advancing Public-Private Partnerships, on September 23, 2010, ... The event is a premier opportunity for representatives ... together to discuss medical partnerships to benefit our ...
... oil and gas company Rosneft is conducting oil and gas ... gray whale to flee its main feeding ground. ... major seismic survey began in late August, despite repeated calls ... the survey because of potential risks to the whales. ...
Cached Biology News:NIH ramps up Human Microbiome Project 2NIH ramps up Human Microbiome Project 3NIH ramps up Human Microbiome Project 4NIH ramps up Human Microbiome Project 5Sutherland and Berglass to keynote USU-HJF Military Medicine Symposium 2Sutherland and Berglass to keynote USU-HJF Military Medicine Symposium 3Critically endangered whales flee Russian oil, gas boom 2
GRADIENT MAKER, 30 ML, 1 EA. Category: Protein Vertical Instruments....
Recombinant Rat Leptin, CF...
actin from rabbit muscle Cell Biology Cytoskeletal Probes Actin and Actin Probes...
...
Biology Products: